Skip to main content

NorayBio Licenses Noraynet to BioDynamics

NEW YORK (GenomeWeb News) - NorayBio licensed its biopharmaceutical platform to BioDynamics, NorayBio said today.
 
The platform, Noraymet ADME, predicts human pharmacokinetic models of new compounds from in vitro ADME data.
 
NorayBio has licensed the product to Spain's Faes Farma and Finland's Novamass.
 
NorayBio and BioDynamics also plan to co-develop software based on Noraymet ADME to refine human pharmacokinetic modelling.

Filed under

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.